Sleeve Gastrectomy Alters Exosomal miR-497-5p Cargo to Ameliorate Metabolic Dysfunction–Associated Steatotic Liver by Targeting GABARAPL1
Diabetes, Metabolic Syndrome and Obesity · 2026-04 · Volume 19 · 1-13
DOI: 10.2147/dmso.s568182 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Metabolic Syndrome and Obesity, 2026-04. Verfasst von Zenghui Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Surgery Centre of Diabetes Mellitus, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People's Republic of China. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Surgery Centre of Diabetes Mellitus, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People's Republic of China.
- Department of General Surgery, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, People's Republic of China.
ORCID-Profile: Mengqin Wang, Zhehong Li, Liang Wang
Zitieren
APA
Li, Z., Tian, C., Wang, M., Li, Z., Wang, L., Wang, Z., Yu, C., Wang, D., Lian, D., & Zhang, N. (2026). Sleeve Gastrectomy Alters Exosomal miR-497-5p Cargo to Ameliorate Metabolic Dysfunction–Associated Steatotic Liver by Targeting GABARAPL1. Diabetes, Metabolic Syndrome and Obesity, Volume 19, 1-13. https://doi.org/10.2147/dmso.s568182
Vancouver
Li Z, Tian C, Wang M, Li Z, Wang L, Wang Z, et al. Sleeve Gastrectomy Alters Exosomal miR-497-5p Cargo to Ameliorate Metabolic Dysfunction–Associated Steatotic Liver by Targeting GABARAPL1. Diabetes, Metabolic Syndrome and Obesity. 2026;Volume 19:1-13. doi:10.2147/dmso.s568182
BibTeX
@article{Li2026,
author = {Li, Zenghui and Tian, Chenxu and Wang, Mengqin and Li, Zhehong and Wang, Liang and Wang, Zheng and Yu, Chengyuan and Wang, Dezhong and Lian, Dongbo and Zhang, Nengwei},
title = {Sleeve Gastrectomy Alters Exosomal miR-497-5p Cargo to Ameliorate Metabolic Dysfunction–Associated Steatotic Liver by Targeting GABARAPL1},
journal = {Diabetes, Metabolic Syndrome and Obesity},
year = {2026},
volume = {Volume 19},
pages = {1--13},
doi = {10.2147/dmso.s568182}
}
EUVIMED